CCR4 and neoplasm: In patients with ovarian carcinoma, the host response to the tumor has been shown to be inhibited by Foxp3+CCR4+ Tregs recruited to the tumor by chemokines including CCL22 (50) and the CCR4-CCL22 axis appears to be operational in tolerized cardiac allografts (51).